Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TRK-IN-21 (5n) is an orally active TRK inhibitor. TRK-IN-21 acts on TRKAWT (IC50: 0.3 nM), TRKAG667C (IC50: 2.3 nM), TRKAF589L (IC50: 0.4 nM) and TRKAG595 (IC50: 0.5 nM). TRK-IN-21 can be used to study cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | TRK-IN-21 (5n) is an orally active TRK inhibitor. TRK-IN-21 acts on TRKAWT (IC50: 0.3 nM), TRKAG667C (IC50: 2.3 nM), TRKAF589L (IC50: 0.4 nM) and TRKAG595 (IC50: 0.5 nM). TRK-IN-21 can be used to study cancer. |
Molecular Weight | 424.45 |
Formula | C22H22F2N6O |
CAS No. | 2429985-55-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TRK-IN-21 2429985-55-5 inhibitor inhibit